Back to top

Jarden Sticks to Its Buy Rating for Regis Healthcare Ltd. (REG)

In a report released on September 15, Steven Wheen from Jarden maintained a Buy rating on Regis Healthcare Ltd., with a price target of A$8.95. The...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regency Centers Corporation (REG)